Frontiers in Immunology | Cancer Immunity and Immunotherapy

Clinical Trial

Published on 12 May 2025

Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Xuwei Chen
Hengming Ye
Daming Xu
Siqi Chen
Wei Wu
Xiaoyu Qian
Xinyu Zhang
Xuxiazi Zou
Junquan Chen
Xi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1570394

322 views

Case Report

Accepted on 09 May 2025

Case Report: Regenerative Hepatic Pseudotumor Induced by Tislelizumab in a Lung Cancer Patient

in Cancer Immunity and Immunotherapy

Wenrui Wang
Wei Li
Tianqi Zhang
Zhenjing Jin
Lanlan Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565065

Review

Accepted on 09 May 2025

Research Progress of B7-H3 in Malignant Tumors

in Cancer Immunity and Immunotherapy

Shuaixiang Zhao
Guanning Shang
He Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1586759

Original Research

Accepted on 09 May 2025

Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment. genes was constructed

in Cancer Immunity and Immunotherapy

Meng Lifei
Simeng Ren
Jun Wang
Weijun Zhao
Jian Chen
Wentao Hu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601982

Original Research

Accepted on 09 May 2025

Transcriptional profiling reveals H.pylori-assocaited genes induced inflammatory cell infiltration and chemoresistance in gastric cancer

in Cancer Immunity and Immunotherapy

Xuehui Hong
Jinshui Tan
Zhengxin Wu
Yuankun Liu
Wei Wang
Wenjuan Qin
Guangchao Pan
Yubo Xiong
Jingsong Ma
Jiabao Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1592558

Original Research

Accepted on 09 May 2025

Immunological Biomarkers and Gene Signatures Predictive of Radiotherapy Resistance in Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Jie Lv
Chun-yang Yu
Yaozu Xiong
Tingting Dai
Xiao-Chu Hu
Peng Pan
Shun Yue
Changhua Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1574113

Review

Accepted on 09 May 2025

Bispecific Antibody for Lung Cancer: Mechanisms and Clinical Insights

in Cancer Immunity and Immunotherapy

Wei Chen
Afang Zhou
Yunfeng Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1572802

107 views

Original Research

Accepted on 09 May 2025

CyTOF Reveals Platelet Subtype Changes Predicting the Efficacy of Combined Immunotherapy and Targeted Therapy in Liver Cancer

in Cancer Immunity and Immunotherapy

Junfeng Lu
Wenjing Wang
Dan Liu
Lilin Wang
Maimaitijiang Wubuli Aishan
Li Chen
Sujun Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1538652

Original Research

Published on 09 May 2025

Impact of pneumonitis from radiotherapy combined with immune checkpoint inhibitors therapy on tumor progression and survival in patients with non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Ziwei Wang
Kunpeng Xu
Han Sun
Jun Liang
Wei Jiang
Luhua Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578057

420 views

Mini Review

Published on 09 May 2025

Mechanisms of autoimmune-mediated paraneoplastic syndromes: immune tolerance and disease pathogenesis

in Cancer Immunity and Immunotherapy

César Pérez-Bucio
Anish Behere
Nils Landegren

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608934

468 views

Systematic Review

Published on 09 May 2025

A comprehensive bibliometric analysis of ferroptosis in tumor resistance: development and emerging trends

in Cancer Immunity and Immunotherapy

Liangyun Xie
Yafei Zhang
Xiedong Niu
Yuan Kang
Wenyao Li
Jun Yao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1580222

378 views

Systematic Review

Published on 09 May 2025

Research trends on lactate in cancer: a bibliometric analysis and comprehensive review (2015–2024)

in Cancer Immunity and Immunotherapy

Sinong Li
Ziyi Yang
Mutian Lv
Lin Zong
Yihan Xie
Zoujuan Cai
Ying Zhang
Zhongqing Wang
Zhe Liu
Liang Sang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1587867

551 views

Methods

Published on 09 May 2025

Engineering safe anti-CD19-CD28ζ CAR T cells with CD8a hinge domain in serum-free media for adoptive immunotherapy

in Cancer Immunity and Immunotherapy

Muthuganesh Muthuvel
Thamizhselvi Ganapathy
Trent Spencer
Sunil S. Raikar
Saravanabhavan Thangavel
Alok Srivastava
Sunil Martin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1545549

754 views

Editorial

Published on 09 May 2025

Editorial: Innate immune pathways as targets for developing therapeutic intervention against human cancers

in Cancer Immunity and Immunotherapy

Fabio Grizzi
Miguel Martin-Perez
Geeta Rai
Abdullah Farhan ul Haque Saeed
Ayush Raman
Devivasha Bordoloi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1595279

590 views

Mini Review

Published on 09 May 2025

The distinct role of IL-34 and IL-35 in gastric cancer

in Cancer Immunity and Immunotherapy

Zhiyun He
Jie Dang
Xiang Cui
Bo Li
Shisan Bao
Jingchun Fan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559508

359 views

Original Research

Published on 09 May 2025

Clinicopathological features and genetic mutation spectrum of primary anastomosing hemangioma arising from the kidney

in Cancer Immunity and Immunotherapy

Luxin Zhang
Haozhen Li
Heyao Tong
Hepeng Cui
Huahang Guo
Shuang Wen
Zhuwei Song
Jiaqiang Chen
Shengxiang Xiang
Zhiyu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554203

542 views